Jason H Gill

9PUBLICATIONS
16CO-AUTHORS
Tissue engineeringBiologically active moleculesCardiology (incl. cardiovascular diseases)Medical molecular engineering of nucleic acids and proteinsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 01, 2025
Development of novel benzamide class I selective lysine deacetylase inhibitors as potent anticancer agents.

Jason H Gill, Jonathan D Sellars, Paul G Waddell

|Jun 14, 2023
Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction.

Rachael E Redgrave, Emily Dookun, Laura K Booth

|May 28, 2020
Identification of Substituted Amino Acid Hydrazides as Novel Anti-Tubercular Agents, Using a Scaffold Hopping Approach.

Alistair K Brown, Ahmed K B Aljohani, Fatimah M A Alsalem

|Jan 23, 2020
Anticancer RuII and RhIII Piano-Stool Complexes that are Histone Deacetylase Inhibitors.

Jasmine M Cross, Tim R Blower, Natalie Gallagher

Pageof 2